1. Business Overview: A Hub for Complex Care
Established in 2008 by renowned neurosurgeon Dr. Mosesjoseph Arunkumar, Hannah Joseph Hospital has grown from a specialized neurology clinic into a 150-bed multi-specialty tertiary care center in Madurai, Tamil Nadu.
The hospital is a regional referral center for:
Neurosciences: Complex brain and spinal surgeries, aneurysm coiling, and stroke management.
Cardiac Sciences: Equipped with a modern Cath Lab for coronary angioplasties and open-heart surgeries.
Trauma & Critical Care: 24/7 emergency services specialized in accident and head injury recovery.
Accreditations: The facility is both NABH and NABL accredited, reflecting international standards of safety and clinical excellence.
2. Key IPO Details & Timeline
The IPO is a 100% Fresh Issue, ensuring that the entire capital raised will be used to fund the hospital's infrastructure and technology upgrades.
| Event | Date / Details |
|---|---|
| IPO Open Date | Thursday, January 22, 2026 |
| IPO Close Date | Tuesday, January 27, 2026 |
| Price Band | ₹67 to ₹70 per share |
| Lot Size | 2,000 Shares |
| Minimum Investment (Retail) | ₹2,80,000 (for 2 lots/4,000 shares) |
| Allotment Finalization | Wednesday, January 28, 2026 |
| Listing Date (Tentative) | Friday, January 30, 2026 |
| Listing Platform | BSE SME |
3. Financial Performance: Scaling Profitability
The hospital has shown a steady upward trend in its financial metrics over the last three fiscal years:
Revenue: Grew from ₹54.90 Cr (FY23) to ₹77.90 Cr (FY25).
Profit After Tax (PAT): Increased significantly from ₹1.01 Cr (FY23) to ₹7.21 Cr (FY25).
EBITDA Margin: A healthy 27.38% as of September 2025.
Return on Equity (ROE): 14.77% (FY25), showing efficient use of shareholder capital.
4. Objectives of the Issue
The primary goal of this IPO is to transform the hospital into a comprehensive cancer care provider:
Radiation Oncology Centre (₹34.98 Cr): Establishing a new wing for advanced cancer treatment, including targeted radiation therapy.
General Corporate Purposes: Strengthening operational liquidity and meeting offer-related expenses.
5. Investment Analysis: Strengths vs. Risks
Strengths:
Specialized Moat: High barriers to entry in neurosurgery and cardiac care compared to general nursing homes.
Proven Leadership: Led by promoters with over 25 years of specialized medical experience.
Government Tie-ups: Empanelled under TNNHIS and CMCHIS, allowing a steady flow of patients through state insurance schemes.
Risks:
Geographic Concentration: Entirely dependent on a single location in Madurai.
Capacity Utilization: Current bed occupancy stands at approximately 38%, indicating significant room for operational improvement.
Regulatory Sensitivity: The healthcare sector is subject to strict pricing caps and compliance audits.
6. Conclusion
Hannah Joseph Hospital is a "Growth + Value" play in the healthcare SME space. With a post-IPO P/E ratio of approximately 15x to 16x, it is priced reasonably compared to listed peers like Asarfi Hospital (P/E ~32x). While the geographical concentration is a risk, the high-margin nature of neuro and cardiac procedures makes this an attractive long-term prospect for investors interested in regional healthcare leaders.